Kyntra Bio (KYNB)

• Market cap: $33.7M
• 1 day: 6.38%
• 5 days: 11.2%
• 1 month: -2.46%
• 3 months: 0.48%
• 6 months: -21.47%
• Year to date: -8.95%
• 1 year: -56.81%
• 5 years: -99.35%
• 10 years: -98.28%
• Sector: Healthcare
• Industry: Biotechnology

About: Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Employees: 225